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ABSTRACT
Purpose: The Royal College of General
Practitioners Research and Surveillance Centre
(RCGP RSC) is one of the longest established
primary care sentinel networks. In 2015, it
established a new data and analysis hub at the
University of Surrey. This paper evaluates the
representativeness of the RCGP RSC network
against the English population.
Participants and method: The cohort includes
1 042 063 patients registered in 107 participating
general practitioner (GP) practices. We compared
the RCGP RSC data with English national data in
the following areas: demographics; geographical
distribution; chronic disease prevalence,
management and completeness of data recording;
and prescribing and vaccine uptake. We also
assessed practices within the network participating
in a national swabbing programme.
Findings to date: We found a small over-
representation of people in the 25–44 age band,
under-representation of white ethnicity, and of less
deprived people. Geographical focus is in London,
with less practices in the southwest and east of
England. We found differences in the prevalence of
diabetes (national: 6.4%, RCPG RSC: 5.8%),
learning disabilities (national: 0.44%, RCPG RSC:
0.40%), obesity (national: 9.2%, RCPG RSC: 8.0%),
pulmonary disease (national: 1.8%, RCPG RSC:
1.6%), and cardiovascular diseases (national: 1.1%,
RCPG RSC: 1.2%). Data completeness in risk factors
for diabetic population is high (77–99%). We found
differences in prescribing rates and costs for
infections (national: 5.58%, RCPG RSC: 7.12%), and
for nutrition and blood conditions (national: 6.26%,
RCPG RSC: 4.50%). Differences in vaccine uptake
were seen in patients aged 2 years (national: 38.5%,
RCPG RSC: 32.8%). Owing to large numbers, most
differences were significant ( p<0.00015).
Future plans: The RCGP RSC is a representative
network, having only small differences with the
national population, which have now been quantified
and can be assessed for clinical relevance for
specific studies. This network is a rich source for
research into routine practice.
INTRODUCTION
Data from primary care sentinel networks is
widely used in research and surveillance;1 the
Royal College of General Practitioners
Research and Surveillance Centre (RCGP
RSC) is one of the longest established.2 These
networks are of particular importance for con-
ditions largely managed in primary care.3
However, outputs may be biased if the sample
is not representative of the monitored popula-
tion, or if there is uncertainty about the
denominator.4 Estimating rates of disease is
easiest from countries that have registration-
based primary care systems,5 though useful
data can be obtained from health systems that
do not require registration.6
Demographics and geographical spread are
important, and many sentinel networks are
involved in the surveillance of infectious condi-
tions, such as inﬂuenza, and assessment of
vaccine effectiveness. Different age-groups and
differing levels of deprivation have different
Strengths and limitations of this study
▪ The Royal College of General Practitioners
Research and Surveillance Centre network is rep-
resentative of the national population on a variety
of domains, both demographic and clinical,
which support the network’s suitability for real-
world evidence research.
▪ Statistically significant differences have been
found, due to the large numbers of the sample,
but this profile has now quantified them, so that
they can be assessed on a study-by-study basis
for their clinical relevance.
▪ Some of the analysis compared data extracted
using different methodology, which may have
skewed the results.
▪ The network is comprised of volunteer practices,
with better management of clinical conditions,
which may introduce a bias to research into clin-
ical outcomes.
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rates of many illnesses, including rates of swab-conﬁrmed
inﬂuenza.7 There are also disparities associated with ethni-
city, though these are not consistent.8–10
For infectious diseases like inﬂuenza, geographic
spread of sentinel practices is important, as well as con-
sistent case ascertainment from year to year.11 It is also
important that the characteristics of the participating
practices are representative.12 In particular, when asses-
sing vaccine effectiveness, vaccine uptake needs to be
properly recorded within the database, in a way that is
representative of the national population rates.13
Disease, prescription and vaccination patterns, as well
as the underlying population demographics, are inter-
related. Any assessment of quality requires an assessment
of the rate of case ascertainment followed by an evalu-
ation of the management of the condition.14 Some senti-
nel networks have focused on the management of
long-term conditions, including diabetes.15 Chronic con-
ditions, such as diabetes, beneﬁt from improved record-
ing of comorbidities and risk factors.
The RCGP RSC is a network of general practices,
which extracts data from the computerised medical
record systems of over 100 practices in England. The
network established a weekly returns service in 1964,
which has enabled prompt surveillance of infectious dis-
eases and identiﬁcation of epidemics; with inﬂuenza sur-
veillance as a key priority for the network.
The characteristics of the RCGP RSC practice network
have previously been compared with population-level
data to ascertain the representativeness of the sample.16
However, since the most recent report in 2009, there
have been substantial changes within the network,
including the commissioning in 2015 of an entirely new
data and analytics hub at the University of Surrey.
We carried out this study to describe the representa-
tiveness of the RCGP RSC practice network comparing
population demographics; geographical distribution; the
prevalence and management of chronic conditions, and
data completeness taking type 2 diabetes mellitus
(T2DM) as an exemplar condition; medication prescrib-
ing; and vaccine uptake.
METHODS
We compared four key areas of representativeness with
the national population:
▸ Demographics: age, gender, ethnicity and
deprivation;
▸ Geographical distribution;
▸ Prevalence andmanagement of chronic conditions, and
the data completeness of risk factors for T2DM patients;
▸ Medications prescribing rates and costs, and inﬂu-
enza vaccine uptake.
We also compared the demographic characteristics of
the practices within the RCGP RSC network which
provide nasopharyngeal virology swabbing specimens for
Public Health England’s (PHE) viral infection surveil-
lance programme, with those that do not. The data for
this study was extracted from practices providing data
uploads in March 2015 into the new RCGP RSC data
upload system. RCGP RSC member practices are all
volunteers who sign a written agreement to participate
in surveillance and research. The practice upload
includes all registered patients’ coded data.
The data extracted by the RCGP RSC sentinel system
is the principal primary care public health surveillance
data used by PHE. All data extracted are pseudonymised
as close to source as possible, and kept in a secure
network database. Patients with ﬂags in their records
suggesting they have opted out of data sharing do not
have their data retained or analysed. Data used for sur-
veillance is part of direct patient care. However, all
planned research use of this data requires review by
research ethics committees prior to use.
Population demographics
The RCGP RSC population was divided by gender,
aggregated into the age bands used in the 2011 Census
for England and Wales, and compared with national
census data available from the Ofﬁce for National
Statistics. Age was calculated from the date of birth at
the point of extraction. Similarly, patients were classiﬁed
into ﬁve ethnic groups (according to census categories),
and compared against national data. We used an
updated version of an established ethnicity classiﬁcation
mapping to maximise the use of any ethnicity data.17
In the process of data extraction, patient postcodes
were converted into Lower Super Output Areas
(LSOAs),18 and these were used to assign an Index of
Multiple Deprivation (IMD) score to each patient.19
Postcode data was then removed from the ﬁnal extract
to maintain pseudonymisation. We also compared the
demographics (age, gender, ethnicity and IMD scores)
of practices providing viral throat swabs for PHE with
practices which do not.
Geographic distribution
We used LSOA data, coordinates and map ﬁles provided
by the Ofﬁce for National Statistics geographical
survey,20 to display the geographical distribution of the
practices. Using each GP practice postcode, we plotted
this against a map of English Clinical Commissioning
Group (CCG) regions, using the statistical software R,
and the package maptools.21
Chronic conditions
We compared the prevalence and quality of manage-
ment of key chronic diseases. We used the data collected
for a national pay-for-performance scheme, the Quality
Outcomes Framework (QOF), to compare the preva-
lence of chronic conditions that are part of the
scheme,22 for RCGP RSC practices and at the national
level. QOF quality points were used as a surrogate of the
quality of care and management of these conditions.
Additionally, we selected diabetes as an exemplar con-
dition to demonstrate the level of data quality found in
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the database for chronic conditions. We assessed the
level of completeness in data recording for a number of
demographics (age, gender, deprivation) and risk
factors (smoking status; systolic blood pressure; body
mass index (BMI, or height and weight); ethnicity; chol-
esterol and glycaemic control), within the RCGP RSC
database.
We only analysed coded data to deﬁne data complete-
ness; while free-text data can be extracted, there are
risks of extracting patient-identiﬁable data, so this data is
not used within the RCGP RSC network. Coded data in
primary care has been widely used in health outcomes
research,23 and has known strengths and limitations.5
Medication prescribing and vaccine uptake
Prescription data for England was collated via the
Prescription Cost Analysis 2014 report,24 and these were
compared with the RCGP RSC data for the same year.
We calculated proportions for the most commonly pre-
scribed British National Formulary (BNF) chapters
(gastrointestinal, cardiovascular, respiratory, central
nervous, endocrine, nutrition/blood and infections),
and compared these with the national proportions.
The average cost per item of each BNF chapter was
multiplied by the quantities prescribed to obtain costs
per chapter, for both the RCGP RSC practices and
national data. Additionally, we compared inﬂuenza
vaccine uptake in the RCGP RSC database with national
rates published by PHE,25 focusing on four at-risk age
groups (children aged 2, 3, 4 and over 65 years old).
Statistical analyses
We used standard descriptive statistics to compare the
RCGP RSC with national data. The χ2 test was used to
compare proportions across most variables. Differences
in the cumulative frequency distribution of IMD scores
were assessed using the Kolmogorov-Smirnov test. The
statistical software R was used for all tests of signiﬁcance,
and the p value was reported. Owing to the large
number of statistical tests (69 tests), we applied a
Bonferroni-Šidák correction26 27 to a level of signiﬁcance
of 0.01, resulting in a new level of signiﬁcance of
0.00015 (Equation 1). This version of the correction was
used since all the tests are independent.
Bonferroni-Šidák equation
a0 ¼ 1 ð1 aÞ1=m ð1Þ
a′=new signiﬁcance level, α=current signiﬁcance level,
m=number of tests.
COHORT DESCRIPTION AND FINDINGS TO DATE
The cohort includes data from 1 042 063 patients regis-
tered at the time of data upload in one of the 107 par-
ticipating practices.
Population demographics
Data for age and gender was recorded for the complete
RCGP RSC population. The age and gender distribution
of the RCGP RSC population was similar to the census dis-
tribution (ﬁgure 1 and online supplementary table S1).
There was a signiﬁcantly higher proportion of both males
and females in the 25–44 years age band when compared
with the census, and a lower proportion of people in the
0–4 years age band. All differences were statistically signiﬁ-
cant; with the exception of people aged 65–74 years, men
aged 45–64 years and women aged 5–14 years.
The ethnicity of 630 754 (61%) patients from the
RCGP RSC cohort was identiﬁed from their medical
records. The proportions of the ﬁve census ethnicity
groups were similar to those from census data (see
online supplementary ﬁgure S1 and table S2). The
majority of patients in the RCGP RSC cohort were of
white ethnicity (84.4%), similar to the census population
(85.4%). Owing to the large numbers, the differences
between the census and RCGP RSC data were signiﬁ-
cant, even when applying a Bonferroni-Šidák correction.
IMD scores were calculated for all patients included in
the analysis, using LSOAs (see online supplementary
ﬁgure S2). The mean IMD score for the RCGP RSC
population was 19.8 (SD 0.00682), which was less
deprived than the English population (mean IMD score
21.8; SD 0.00050). This is mostly due to a small over-
representation of patients in the two least deprived
deciles (see online supplementary ﬁgure S3). The
Kolmogorov-Smirnov test showed that this difference was
signiﬁcant.
Figure 1 Age-gender profile for
the Royal College of General
Practitioners Research and
Surveillance Centre (RCGP RSC)
compared with the census
population.
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The demographic characteristics of the practices par-
ticipating in the PHE swabbing programme were com-
pared with non-participating practices. There was a
signiﬁcantly higher proportion of people in the 25–
44 years age band for participating practices, and a
lower proportion of people in the 65+ years band (see
online supplementary ﬁgure S4). All differences were
statistically signiﬁcant, with the exception of men aged
15–24 years and women aged 5–14 years.
Participating practices had signiﬁcantly less people in
the white census group (75%) compared to non-
participating practices (83%), and more people in
ethnic minority groups (see online supplementary
ﬁgure S5). Finally, the population in participating prac-
tices was more deprived (mean IMD score 21.5, SD
0.018) than that of the non-participating practices
(mean IMD score 19.0, SD 0.010, see online supplemen-
tary ﬁgure S6), and the Kolmogorov-Smirnov test
showed this to be signiﬁcant.
Geographic distribution
The RCGP RSC practices are broadly distributed across
England, with a higher concentration of practices in
London, and a slightly lower number in the southwest
and east of England (ﬁgure 2). The distribution shows a
number of practice clusters, probably due to effective
recruitment strategies using the support of CCGs.
Chronic conditions
The prevalence of common chronic diseases was similar
to that reported nationally in the QOF scheme for
chronic disease management (ﬁgure 3 and online sup-
plementary table S3i). Diabetes (national: 6.4%, RCPG
RSC: 5.8%), learning disabilities (national: 0.44%, RCPG
RSC: 0.40%), obesity (national: 9.2%, RCPG RSC:
8.0%), and pulmonary disease (national: 1.8%, RCPG
RSC: 1.6%) are slightly under-represented, while cardio-
vascular diseases (national: 1.1%, RCPG RSC: 1.2%) are
slightly over-represented.
All differences were signiﬁcant, with the exception of
asthma, chronic kidney disease, depression, palliative
care and stroke. The median percentage of QOF targets
achieved by the RCGP RSC network (98.76%; IQR
2.64%) was higher than the national median percentage
Figure 2 Geographical
distribution of the Royal College
of General Practitioners Research
and Surveillance Centre (RCGP
RSC) practices in England.
iThe denominators vary by condition, depending on the QOF
deﬁnition (all population, population over 18 years, etc).
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(97.04%; IQR 5.45%), due to an over-representation of
the network in the higher score deciles (see online sup-
plementary ﬁgure S7).
Diabetes was taken as an exemplar condition to dem-
onstrate the completeness of recorded data within the
RCGP RSC database (table 1). This analysis was per-
formed on patients who have complete data for the past
10 years. The recording of data related to cardiovascular
risk factors ranges from 77% to 99% for the diabetic
population, and from 26% to 69% for the non-diabetic
population. Owing to the introduction of QOF targets,
the data completeness related to risk factors or clinical
management is expected to be higher for patients with
a chronic condition.28
The comparison with non-diabetic patients is provided
to demonstrate the improvement in recording expected
for patients with a chronic condition, compared to those
without. Since the QOF targets incentivise accurate
recording of chronic conditions diagnoses, and of con-
tinuous assessments of risk factors for patients with these
conditions, primary care data is particularly well suited
for longitudinal research into chronic conditions.
Medication prescribing and vaccine uptake
Prescription items and costs by BNF chapters in the
RCGP RSC dataset were compared with national data.
The RCGP RSC had higher prescribing rates and costs
for drugs within the infections chapter (national: 5.58%,
RCPG RSC: 7.12%), while the practices in the network
prescribed less drugs in the nutrition and blood chapter
(national: 6.26%, RCPG RSC: 4.50%). This difference
was signiﬁcant (ﬁgure 4), and it was also reﬂected in the
prescription costs (see online supplementary ﬁgure S8).
Inﬂuenza vaccine exposure rates within the RCGP
RSC network were compared with the national rates
published by PHE. Inﬂuenza vaccine uptake in the
RCGP RSC network is similar to the national rates,
although slightly smaller; these are shown in ﬁgure 5.
The largest difference was seen in the group of patients
aged 2 years (national: 38.5%, RCPG RSC: 32.8%), while
the smallest differences were in the over 65 years olds
(national: 73%, RCPG RSC: 71%).
STRENGTHS AND LIMITATIONS
Strengths
This study shows the representativeness of the RCGP
RSC against nationally published data on a variety of
domains, both demographic and clinical. Beyond the
Figure 3 Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC)-recorded prevalence of
chronic conditions compared with all-English practices, using Quality Outcomes Framework (QOF) data.
Table 1 RCGP RSC data completeness on key variables
for patients with and without diabetes
Variables
Diabetes Non-diabetes
Count
Per
cent Count
Per
cent
Age 39 559 100 977 445 100
Gender 39 559 100 977 445 100
Deprivation score 38 312 97 935 128 96
CV risk factors
Smoking status 38 928 98 669 874 69
Blood pressure
(systolic)
38 935 98 502 188 51
BMI (or height and
weight)
38 225 97 524 384 54
Ethnicity 30 409 77 585 279 60
Cholesterol (HDL,
LDL, other)
37 386 95 293 082 30
Glycaemic control
(blood glucose/
HbA1c)
39 244 99 253 532 26
BMI, body mass index; CV, cardiovascular; HDL, high-density
lipoprotein; LDL, low-density lipoprotein; RCGP RSC, Royal
College of General Practitioners Research and Surveillance
Centre.
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areas concerning surveillance, the RCGP RSC database
is also representative in a number of clinically relevant
areas, which support the network’s suitability for real-
world evidence research.
This paper provided a clear assessment of the preva-
lence of chronic conditions when compared with
national data, and the completeness of recorded data
for risk factors, comparing patients with T2DM and
those without. The purpose of this was to assess the suit-
ability of longitudinal research into chronic conditions.
It was shown that the data completeness for risk factors
drastically improves for patients with an exemplar
chronic condition (T2DM), due to the QOF scheme in
English primary care.
This paper also highlighted key differences of this
network against a national population, due to the nature
of its primary purpose. Prescriptions for infections were
higher than national levels (though not vaccine uptake),
and there was an over-representation of practices in the
higher deciles of QOF scores. This is because the RCGP
RSC is a sentinel network comprised of volunteer prac-
tices, and focused around infectious and respiratory
disease surveillance. These differences have been evalu-
ated in this paper, and their relevance can be consid-
ered for research using this database.
Most of the differences found were statistically signiﬁ-
cant; this is due to the large numbers involved in the ana-
lysis, which means that very small differences can be easily
detected, even when a Bonferroni-Šidák correction is
applied to adjust the signiﬁcance level. Though the differ-
ence introduces a bias to the cohort, it has, nonetheless,
been quantiﬁed in this paper, and can be assessed on a
study-by-study basis for its clinical relevance.
Limitations
An important limitation of this study is that a number of
areas (ethnicity, prescriptions, vaccine uptake) were
assessed by comparing publically available national rates
with data extracted from the RCGP RSC database. The
criteria used to extract the network’s rates may not have
been the same as that used for the published national
data, leading to signiﬁcant differences.
It must be noted that recruitment efforts within the
network continue to be expanded, particularly regard-
ing new projects, such as the Integrate study for gastro-
intestinal disease surveillance29 which is focused in the
northwest of England; this shift in geographical focus
may change the demographic structure of the network.
Therefore, the assessment of representativeness pre-
sented in this paper may change in future.
Figure 4 Prescription items by British National Formulary (BNF) chapter: National and Royal College of General Practitioners
Research and Surveillance Centre (RCGP RSC).
Figure 5 Vaccine exposure:
National and Royal College of
General Practitioners Research
and Surveillance Centre (RCGP
RSC).
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CONCLUSIONS AND FUTURE COLLABORATIONS
This network provides a representative sample of the
population of England in terms of demographics and
clinical outcomes. Future recruitment needs to ensure
that, as far as possible, any areas of difference are mini-
mised. The RCGP RSC network, in addition to surveil-
lance, could also be used for research into routine
practice, and the interaction of infectious disease with
long-term conditions.
The use of large healthcare data sets continues to
expand,30 with many networks having been set up in the
UK providing regular updates to large data sets.31–33
These networks are recognised as having a vital role in
disease surveillance, monitoring response to policy
change, identiﬁcation of health-environment interac-
tions and monitoring of side effects of medication.34–37
More recently, it has been suggested that these large
data networks could also be used to perform large-scale
clinical trials and ensure real-world medication effective-
ness for new medications.38
This is particularly important, as clinical trial popula-
tions are often not representative of the real-world popu-
lation, where any interventions or new treatments are
ultimately implemented.39 40 If clinical outcomes are to
be measured using these data sets, it is important that
they provide a representative sample of the underlying
population, reporting any deviations. The RCGP RSC
network is representative of the underlying English
population, and key signiﬁcant differences have been
clearly quantiﬁed in this paper, making this database a
rich source for health outcomes research.
It is expected that this database will be available to
researchers on a case-by-case basis. Ethical approval by the
NHS Research Ethics Committee is needed for data
requests to be considered. Data requests for aggregated
data will be provided by the University of Surrey team.
Researchers wishing to directly analyse the patient-level
anonymised data will be required to complete information
governance training and work on the data from the secure
servers at the University of Surrey. We encourage interested
researchers to attend the short courses on how to analyse
primary-care data offered by the university twice a year.
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